Dynavax Technologies Corporation
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Dynavax Technologies Corporation
The year began with an unusually low number of CRLs, but a recent burst of non-approval actions suggests a COVID-19 effect.
New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.
GlaxoSmithKline's first-of-its kind treatment for multiple myeloma is among 11 new medicines that have won an EU approval nod from the European Medicines Agency this week.
GlaxoSmithKline's potential multiple myeloma treatment is one of several new products that could get an EU marketing thumbs up from the European Medicines Agency this week.
- Drug Delivery
- Antisense, Oligonucleotides
- Drug Discovery Tools
- Large Molecule
- Other Names / Subsidiaries
- Symphony Dynamo, Inc. (SDI)